Research Article
Synthesis of Novel Diclofenac Hydrazones: Molecular Docking, Anti-Inflammatory, Analgesic, and Ulcerogenic Activity
Table 6
Docking energies of the compounds with COX-1 and COX-2 proteins.
| Compd. | Energies Cox-1 (kJ/mol) | Energies Cox-2 (kJ/mol) | Compd. | Energies Cox-1 (kJ/mol) | Energies Cox-2 (kJ/mol) |
| 1 | −8.8 | −10 | 8 | −9.4 | −9.4 | 2 | −8.4 | −10 | 9 | −8.3 | −9.6 | 3 | −8.7 | −9.9 | 10 | −8.3 | −9.6 | 4 | −9.2 | −9.8 | 11 | −8.4 | −9.5 | 5 | −8.5 | −9.7 | 12 | −9.1 | −9.9 | 6 | −8.5 | −10.4 | 13 | −9.8 | −9.9 | 7 | −8.2 | −9.6 | 14 | −8.8 | −10 | | | | Diclofenac | −6.6 | −8.1 |
|
|